| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microcephaly | 44 | 2023 | 425 | 6.740 |
Why?
|
| Cerebral Cortex | 94 | 2023 | 5761 | 6.160 |
Why?
|
| Malformations of Cortical Development | 20 | 2022 | 177 | 5.000 |
Why?
|
| Neurons | 103 | 2024 | 9426 | 4.880 |
Why?
|
| Neurogenesis | 18 | 2024 | 856 | 3.490 |
Why?
|
| Nervous System Malformations | 21 | 2023 | 244 | 3.030 |
Why?
|
| Mutation | 111 | 2024 | 29932 | 3.020 |
Why?
|
| Brain | 94 | 2024 | 26951 | 3.020 |
Why?
|
| Microtubule-Associated Proteins | 29 | 2018 | 1077 | 2.940 |
Why?
|
| Mosaicism | 12 | 2024 | 466 | 2.800 |
Why?
|
| Neural Stem Cells | 15 | 2024 | 884 | 2.560 |
Why?
|
| Brain Diseases | 24 | 2023 | 1540 | 2.450 |
Why?
|
| Neocortex | 13 | 2024 | 416 | 2.240 |
Why?
|
| Contractile Proteins | 21 | 2012 | 240 | 2.170 |
Why?
|
| DNA Copy Number Variations | 14 | 2024 | 2013 | 2.170 |
Why?
|
| Autistic Disorder | 14 | 2024 | 1216 | 2.050 |
Why?
|
| Nerve Tissue Proteins | 38 | 2024 | 4407 | 2.020 |
Why?
|
| Ferrets | 14 | 2024 | 176 | 1.910 |
Why?
|
| Pedigree | 66 | 2021 | 4578 | 1.900 |
Why?
|
| Cell Movement | 48 | 2020 | 5206 | 1.850 |
Why?
|
| Cerebral Ventricles | 22 | 2023 | 542 | 1.770 |
Why?
|
| Neuropeptides | 19 | 2015 | 943 | 1.740 |
Why?
|
| Gene Expression Regulation, Developmental | 36 | 2024 | 3604 | 1.680 |
Why?
|
| Cell Lineage | 13 | 2021 | 2533 | 1.630 |
Why?
|
| Microfilament Proteins | 22 | 2012 | 1135 | 1.620 |
Why?
|
| Single-Cell Analysis | 16 | 2022 | 2380 | 1.580 |
Why?
|
| Developmental Disabilities | 16 | 2021 | 1504 | 1.540 |
Why?
|
| Abnormalities, Multiple | 23 | 2019 | 1415 | 1.530 |
Why?
|
| Centrioles | 6 | 2020 | 79 | 1.500 |
Why?
|
| Homeodomain Proteins | 20 | 2024 | 2414 | 1.500 |
Why?
|
| Genetic Predisposition to Disease | 32 | 2024 | 17790 | 1.490 |
Why?
|
| Biological Evolution | 11 | 2023 | 1074 | 1.480 |
Why?
|
| Choristoma | 15 | 2006 | 207 | 1.410 |
Why?
|
| DNA Mutational Analysis | 36 | 2021 | 4107 | 1.350 |
Why?
|
| Lissencephaly | 5 | 2020 | 36 | 1.320 |
Why?
|
| Hedgehog Proteins | 5 | 2023 | 769 | 1.250 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2016 | 330 | 1.230 |
Why?
|
| Fragile X Syndrome | 3 | 2023 | 116 | 1.200 |
Why?
|
| X Chromosome | 15 | 2001 | 815 | 1.180 |
Why?
|
| Genes, Recessive | 15 | 2019 | 626 | 1.180 |
Why?
|
| Homozygote | 21 | 2021 | 1788 | 1.160 |
Why?
|
| Prosencephalon | 6 | 2021 | 305 | 1.140 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 3 | 2020 | 150 | 1.110 |
Why?
|
| Trisomy | 4 | 2024 | 260 | 1.100 |
Why?
|
| Phenotype | 59 | 2024 | 16546 | 1.070 |
Why?
|
| Aging | 14 | 2024 | 8651 | 1.070 |
Why?
|
| Cytoskeletal Proteins | 7 | 2020 | 1343 | 1.050 |
Why?
|
| Stem Cells | 24 | 2017 | 3523 | 1.020 |
Why?
|
| Centrosome | 9 | 2019 | 207 | 1.010 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 11 | 2017 | 263 | 1.000 |
Why?
|
| Child Development Disorders, Pervasive | 8 | 2021 | 599 | 0.990 |
Why?
|
| Epilepsy | 20 | 2023 | 3267 | 0.980 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2024 | 362 | 0.970 |
Why?
|
| Animals | 166 | 2024 | 167963 | 0.970 |
Why?
|
| Receptors, G-Protein-Coupled | 11 | 2020 | 1245 | 0.960 |
Why?
|
| Myocytes, Cardiac | 3 | 2022 | 1657 | 0.930 |
Why?
|
| Humans | 299 | 2024 | 760621 | 0.910 |
Why?
|
| Transcription Factors | 22 | 2024 | 12103 | 0.910 |
Why?
|
| Genetic Linkage | 22 | 2017 | 2381 | 0.900 |
Why?
|
| Consanguinity | 19 | 2017 | 456 | 0.890 |
Why?
|
| Mice | 107 | 2024 | 81208 | 0.890 |
Why?
|
| Point Mutation | 9 | 2022 | 1594 | 0.870 |
Why?
|
| Cell Cycle Proteins | 10 | 2020 | 3446 | 0.870 |
Why?
|
| High-Throughput Nucleotide Sequencing | 11 | 2024 | 3616 | 0.870 |
Why?
|
| Neurosciences | 3 | 2018 | 353 | 0.850 |
Why?
|
| Genome, Human | 16 | 2024 | 4417 | 0.850 |
Why?
|
| Gastrulation | 2 | 2021 | 33 | 0.840 |
Why?
|
| Chromosome Mapping | 21 | 2021 | 4625 | 0.840 |
Why?
|
| Chromosomes, Human, Pair 1 | 8 | 2014 | 635 | 0.830 |
Why?
|
| Hydrocephalus | 8 | 2023 | 763 | 0.820 |
Why?
|
| Cerebrospinal Fluid | 5 | 2022 | 544 | 0.790 |
Why?
|
| Chromosomes, Human, Pair 16 | 7 | 2022 | 342 | 0.790 |
Why?
|
| Polymorphism, Single Nucleotide | 27 | 2024 | 15789 | 0.780 |
Why?
|
| Mutation, Missense | 15 | 2023 | 2566 | 0.770 |
Why?
|
| Databases, Genetic | 3 | 2020 | 1738 | 0.760 |
Why?
|
| Frameshift Mutation | 7 | 2021 | 388 | 0.760 |
Why?
|
| Genetic Variation | 12 | 2022 | 6551 | 0.760 |
Why?
|
| Repressor Proteins | 14 | 2017 | 2981 | 0.760 |
Why?
|
| Syndrome | 28 | 2022 | 3280 | 0.750 |
Why?
|
| Genetic Association Studies | 7 | 2023 | 2717 | 0.750 |
Why?
|
| Epilepsies, Partial | 4 | 2021 | 430 | 0.750 |
Why?
|
| Genomics | 9 | 2022 | 5794 | 0.750 |
Why?
|
| Exons | 12 | 2022 | 2388 | 0.750 |
Why?
|
| Nuclear Proteins | 13 | 2023 | 5791 | 0.750 |
Why?
|
| Frontal Lobe | 6 | 2014 | 1420 | 0.740 |
Why?
|
| Periventricular Nodular Heterotopia | 5 | 2018 | 53 | 0.730 |
Why?
|
| Germ-Line Mutation | 10 | 2024 | 1841 | 0.720 |
Why?
|
| Chromosome Deletion | 10 | 2022 | 1387 | 0.710 |
Why?
|
| DNA Repair | 8 | 2022 | 2039 | 0.710 |
Why?
|
| Seizures | 11 | 2021 | 2917 | 0.710 |
Why?
|
| Cell Differentiation | 23 | 2021 | 11481 | 0.700 |
Why?
|
| Extracellular Matrix Proteins | 9 | 2011 | 829 | 0.700 |
Why?
|
| Evolution, Molecular | 9 | 2024 | 1885 | 0.700 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1091 | 0.690 |
Why?
|
| Oligodendroglia | 1 | 2024 | 536 | 0.690 |
Why?
|
| Carrier Proteins | 8 | 2012 | 4938 | 0.670 |
Why?
|
| Sequence Analysis, DNA | 20 | 2020 | 4713 | 0.670 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 112 | 0.660 |
Why?
|
| Microtubules | 8 | 2020 | 1072 | 0.660 |
Why?
|
| Clone Cells | 12 | 2021 | 1660 | 0.660 |
Why?
|
| Chromosomes, Human, Pair 19 | 6 | 2012 | 347 | 0.630 |
Why?
|
| Embryo, Mammalian | 19 | 2015 | 1674 | 0.630 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 477 | 0.620 |
Why?
|
| Telencephalon | 2 | 2017 | 142 | 0.620 |
Why?
|
| Walker-Warburg Syndrome | 3 | 2012 | 15 | 0.610 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 1084 | 0.610 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2019 | 2873 | 0.600 |
Why?
|
| Child | 70 | 2024 | 79806 | 0.600 |
Why?
|
| Genetics | 1 | 2018 | 114 | 0.600 |
Why?
|
| Functional Laterality | 7 | 2010 | 2253 | 0.590 |
Why?
|
| Cell Division | 14 | 2021 | 4463 | 0.590 |
Why?
|
| Female | 158 | 2024 | 391270 | 0.580 |
Why?
|
| DNA Damage | 4 | 2022 | 2442 | 0.580 |
Why?
|
| Membrane Proteins | 11 | 2021 | 7850 | 0.580 |
Why?
|
| Transcription, Genetic | 6 | 2018 | 7593 | 0.570 |
Why?
|
| Male | 148 | 2024 | 359744 | 0.570 |
Why?
|
| Cerebellum | 9 | 2007 | 1496 | 0.570 |
Why?
|
| Microsatellite Repeats | 16 | 2015 | 786 | 0.560 |
Why?
|
| DNA Replication | 5 | 2018 | 1412 | 0.550 |
Why?
|
| DNA Repair-Deficiency Disorders | 2 | 2022 | 36 | 0.550 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 1115 | 0.540 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2018 | 232 | 0.540 |
Why?
|
| Mice, Mutant Strains | 12 | 2010 | 1753 | 0.530 |
Why?
|
| Body Patterning | 4 | 2014 | 632 | 0.530 |
Why?
|
| Cerebellar Cortex | 2 | 2012 | 107 | 0.530 |
Why?
|
| Genetic Techniques | 4 | 2017 | 428 | 0.530 |
Why?
|
| Developmental Biology | 1 | 2017 | 80 | 0.530 |
Why?
|
| Signal Transduction | 19 | 2023 | 23376 | 0.520 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2024 | 698 | 0.520 |
Why?
|
| Osteochondrodysplasias | 1 | 2017 | 182 | 0.520 |
Why?
|
| Child, Preschool | 46 | 2022 | 42063 | 0.520 |
Why?
|
| Cilia | 2 | 2023 | 493 | 0.520 |
Why?
|
| Alleles | 9 | 2022 | 6898 | 0.520 |
Why?
|
| Gene Regulatory Networks | 2 | 2021 | 1741 | 0.520 |
Why?
|
| Prefrontal Cortex | 3 | 2022 | 2212 | 0.520 |
Why?
|
| Behavior | 1 | 2018 | 540 | 0.500 |
Why?
|
| Tetrasomy | 1 | 2014 | 1 | 0.490 |
Why?
|
| Ion Channels | 1 | 2020 | 1043 | 0.490 |
Why?
|
| Sequence Deletion | 10 | 2020 | 1493 | 0.490 |
Why?
|
| Dyslexia | 2 | 2007 | 208 | 0.480 |
Why?
|
| Sex Chromosome Aberrations | 3 | 2001 | 116 | 0.480 |
Why?
|
| Ehlers-Danlos Syndrome | 3 | 2006 | 92 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 53 | 2022 | 36290 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 2 | 9 | 2019 | 313 | 0.470 |
Why?
|
| Infant | 38 | 2021 | 36060 | 0.470 |
Why?
|
| Nervous System Diseases | 3 | 2023 | 1647 | 0.460 |
Why?
|
| Hippocampus | 8 | 2023 | 3738 | 0.460 |
Why?
|
| Epilepsy, Benign Neonatal | 1 | 2013 | 13 | 0.460 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2015 | 678 | 0.460 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2022 | 2058 | 0.450 |
Why?
|
| Vesicular Transport Proteins | 4 | 2018 | 374 | 0.450 |
Why?
|
| Retroelements | 1 | 2015 | 163 | 0.440 |
Why?
|
| Mice, Knockout | 23 | 2023 | 14372 | 0.430 |
Why?
|
| Ependyma | 2 | 2010 | 56 | 0.430 |
Why?
|
| Serine Endopeptidases | 9 | 2011 | 1021 | 0.430 |
Why?
|
| Nervous System | 3 | 2008 | 543 | 0.420 |
Why?
|
| INDEL Mutation | 3 | 2024 | 266 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2011 | 310 | 0.420 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2013 | 159 | 0.410 |
Why?
|
| Adolescent | 45 | 2022 | 87810 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2012 | 66 | 0.410 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 290 | 0.410 |
Why?
|
| Chromosome Duplication | 2 | 2024 | 75 | 0.400 |
Why?
|
| Molecular Sequence Data | 25 | 2016 | 17624 | 0.400 |
Why?
|
| Lod Score | 9 | 2008 | 602 | 0.400 |
Why?
|
| Glycosyltransferases | 1 | 2012 | 118 | 0.390 |
Why?
|
| Family Health | 12 | 2011 | 1257 | 0.390 |
Why?
|
| p21-Activated Kinases | 5 | 2008 | 128 | 0.390 |
Why?
|
| RNA, Messenger | 22 | 2023 | 12766 | 0.390 |
Why?
|
| Rett Syndrome | 1 | 2013 | 164 | 0.390 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 9 | 2010 | 129 | 0.390 |
Why?
|
| Embryonic Development | 4 | 2021 | 716 | 0.390 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 1596 | 0.390 |
Why?
|
| Proteins | 10 | 2011 | 6029 | 0.390 |
Why?
|
| DNA Repair Enzymes | 2 | 2012 | 345 | 0.390 |
Why?
|
| Caudate Nucleus | 2 | 2012 | 389 | 0.390 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 8547 | 0.390 |
Why?
|
| Polymerase Chain Reaction | 15 | 2021 | 6068 | 0.380 |
Why?
|
| Parietal Lobe | 4 | 2008 | 850 | 0.380 |
Why?
|
| Neuroglia | 11 | 2018 | 944 | 0.380 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2012 | 436 | 0.380 |
Why?
|
| DNA-Binding Proteins | 7 | 2017 | 9585 | 0.380 |
Why?
|
| Cyclohexenes | 1 | 2010 | 15 | 0.370 |
Why?
|
| Base Sequence | 20 | 2020 | 12446 | 0.370 |
Why?
|
| Mannosyltransferases | 3 | 2005 | 23 | 0.370 |
Why?
|
| Interneurons | 4 | 2021 | 591 | 0.370 |
Why?
|
| Genotype | 21 | 2023 | 12960 | 0.370 |
Why?
|
| Cerebrum | 1 | 2012 | 132 | 0.370 |
Why?
|
| Axons | 8 | 2011 | 1673 | 0.360 |
Why?
|
| Chromatin | 5 | 2024 | 2938 | 0.360 |
Why?
|
| Muscular Dystrophies | 3 | 2013 | 389 | 0.360 |
Why?
|
| Genes | 3 | 2000 | 1845 | 0.360 |
Why?
|
| Carboxy-Lyases | 1 | 2010 | 85 | 0.360 |
Why?
|
| Gene Deletion | 8 | 2020 | 2668 | 0.360 |
Why?
|
| Central Nervous System | 6 | 2023 | 1334 | 0.360 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 832 | 0.360 |
Why?
|
| Cell Proliferation | 12 | 2024 | 10446 | 0.360 |
Why?
|
| Infant, Newborn | 21 | 2021 | 26181 | 0.350 |
Why?
|
| Congenital Abnormalities | 4 | 2022 | 704 | 0.340 |
Why?
|
| Dendrites | 5 | 2017 | 475 | 0.340 |
Why?
|
| Chromosome Aberrations | 6 | 2024 | 1764 | 0.340 |
Why?
|
| Social Behavior | 1 | 2016 | 1131 | 0.340 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2010 | 140 | 0.340 |
Why?
|
| Maternal Age | 1 | 2012 | 807 | 0.340 |
Why?
|
| Embryonic Induction | 2 | 2001 | 151 | 0.330 |
Why?
|
| Eye Abnormalities | 4 | 2008 | 241 | 0.330 |
Why?
|
| Paraplegia | 1 | 2010 | 162 | 0.330 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 698 | 0.330 |
Why?
|
| Gene Expression | 8 | 2021 | 7588 | 0.330 |
Why?
|
| RNA Splicing | 4 | 2017 | 915 | 0.320 |
Why?
|
| Mice, Neurologic Mutants | 5 | 2004 | 107 | 0.320 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2010 | 286 | 0.320 |
Why?
|
| Pan troglodytes | 4 | 2023 | 224 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2022 | 2448 | 0.320 |
Why?
|
| Zebrafish | 8 | 2020 | 2997 | 0.310 |
Why?
|
| Oman | 5 | 2015 | 17 | 0.310 |
Why?
|
| Organogenesis | 3 | 2021 | 215 | 0.310 |
Why?
|
| Adult | 55 | 2024 | 219994 | 0.310 |
Why?
|
| Cataract | 2 | 2013 | 827 | 0.310 |
Why?
|
| Tight Junctions | 1 | 2010 | 315 | 0.300 |
Why?
|
| Cell Adhesion Molecules | 2 | 2013 | 1602 | 0.300 |
Why?
|
| Cell Polarity | 2 | 2011 | 638 | 0.300 |
Why?
|
| NF-kappa B | 2 | 2014 | 2488 | 0.300 |
Why?
|
| Holoprosencephaly | 2 | 2005 | 22 | 0.300 |
Why?
|
| Animals, Newborn | 11 | 2010 | 2672 | 0.300 |
Why?
|
| Mental Disorders | 5 | 2023 | 6796 | 0.300 |
Why?
|
| Organ Size | 5 | 2018 | 2254 | 0.290 |
Why?
|
| Organoids | 1 | 2013 | 729 | 0.290 |
Why?
|
| Carnivora | 4 | 1987 | 25 | 0.290 |
Why?
|
| Retroviridae | 12 | 2002 | 850 | 0.290 |
Why?
|
| Brain Stem | 5 | 2022 | 857 | 0.290 |
Why?
|
| Tuberous Sclerosis | 2 | 2013 | 1030 | 0.280 |
Why?
|
| Genes, Developmental | 1 | 2007 | 38 | 0.280 |
Why?
|
| Brain Chemistry | 3 | 2021 | 959 | 0.280 |
Why?
|
| Sequence Analysis, RNA | 5 | 2022 | 2005 | 0.280 |
Why?
|
| Cells, Cultured | 18 | 2021 | 18957 | 0.280 |
Why?
|
| Gyrus Cinguli | 2 | 2010 | 1114 | 0.280 |
Why?
|
| Pregnancy | 19 | 2023 | 29749 | 0.270 |
Why?
|
| Macaca | 3 | 2024 | 409 | 0.270 |
Why?
|
| Blotting, Western | 10 | 2016 | 5039 | 0.270 |
Why?
|
| In Situ Hybridization | 8 | 2010 | 1900 | 0.270 |
Why?
|
| Directed Molecular Evolution | 1 | 2007 | 158 | 0.270 |
Why?
|
| Ligases | 1 | 2007 | 332 | 0.260 |
Why?
|
| Calcinosis | 2 | 2013 | 1476 | 0.250 |
Why?
|
| Neurology | 1 | 2013 | 779 | 0.250 |
Why?
|
| Prenatal Care | 1 | 2012 | 1129 | 0.250 |
Why?
|
| Contig Mapping | 2 | 2002 | 54 | 0.250 |
Why?
|
| Trans-Activators | 3 | 2005 | 2860 | 0.240 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 622 | 0.240 |
Why?
|
| Codon, Nonsense | 4 | 2015 | 281 | 0.240 |
Why?
|
| POU Domain Factors | 1 | 2024 | 47 | 0.240 |
Why?
|
| Mitosis | 6 | 2015 | 1191 | 0.240 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2015 | 2895 | 0.240 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2008 | 568 | 0.240 |
Why?
|
| Mice, Transgenic | 13 | 2017 | 9530 | 0.240 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 2 | 2014 | 13 | 0.240 |
Why?
|
| Gene Expression Regulation | 8 | 2022 | 11903 | 0.230 |
Why?
|
| Cognition | 3 | 2023 | 6957 | 0.230 |
Why?
|
| Gene Expression Profiling | 7 | 2023 | 9411 | 0.230 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 670 | 0.230 |
Why?
|
| Genome-Wide Association Study | 7 | 2021 | 12626 | 0.230 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2024 | 91 | 0.230 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 666 | 0.220 |
Why?
|
| Gene Dosage | 6 | 2020 | 1218 | 0.220 |
Why?
|
| Cell Communication | 4 | 2013 | 1653 | 0.220 |
Why?
|
| Fetus | 5 | 2022 | 1859 | 0.220 |
Why?
|
| Chromosomes, Human, X | 5 | 2011 | 321 | 0.220 |
Why?
|
| Hominidae | 1 | 2023 | 68 | 0.220 |
Why?
|
| DNA | 10 | 2022 | 7233 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2003 | 1854 | 0.220 |
Why?
|
| Vomeronasal Organ | 1 | 2003 | 20 | 0.220 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2003 | 133 | 0.220 |
Why?
|
| Young Adult | 19 | 2021 | 58741 | 0.220 |
Why?
|
| Optic Nerve | 4 | 1987 | 567 | 0.220 |
Why?
|
| Arthrogryposis | 2 | 2017 | 68 | 0.210 |
Why?
|
| Dystroglycans | 4 | 2014 | 62 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2003 | 489 | 0.210 |
Why?
|
| Rats | 20 | 2013 | 23711 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2014 | 246 | 0.210 |
Why?
|
| Cerebral Hemorrhage | 2 | 2013 | 2660 | 0.210 |
Why?
|
| Nucleotides | 2 | 2022 | 450 | 0.210 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2023 | 247 | 0.210 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2023 | 116 | 0.210 |
Why?
|
| Brain Neoplasms | 3 | 2021 | 8986 | 0.210 |
Why?
|
| alpha-Mannosidase | 1 | 2022 | 20 | 0.200 |
Why?
|
| DNA Primers | 8 | 2010 | 2819 | 0.200 |
Why?
|
| Synapses | 4 | 2014 | 1757 | 0.200 |
Why?
|
| Models, Biological | 6 | 2013 | 9467 | 0.200 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2022 | 26 | 0.200 |
Why?
|
| Tremor | 1 | 2023 | 187 | 0.200 |
Why?
|
| COS Cells | 7 | 2005 | 1129 | 0.200 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 186 | 0.200 |
Why?
|
| Muscle Development | 2 | 2014 | 259 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2024 | 1356 | 0.200 |
Why?
|
| Pons | 1 | 2003 | 239 | 0.200 |
Why?
|
| Genetic Diseases, X-Linked | 5 | 2012 | 378 | 0.200 |
Why?
|
| Olfactory Pathways | 1 | 2003 | 132 | 0.200 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2022 | 48 | 0.200 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 471 | 0.190 |
Why?
|
| Central Nervous System Cysts | 1 | 2022 | 56 | 0.190 |
Why?
|
| Family | 9 | 2018 | 3189 | 0.190 |
Why?
|
| Species Specificity | 4 | 2023 | 2418 | 0.190 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2023 | 387 | 0.190 |
Why?
|
| Oxidative Stress | 2 | 2022 | 3106 | 0.190 |
Why?
|
| Gastrula | 1 | 2021 | 82 | 0.190 |
Why?
|
| Nucleoside-Phosphate Kinase | 2 | 2011 | 25 | 0.190 |
Why?
|
| Synaptic Vesicles | 2 | 2016 | 190 | 0.180 |
Why?
|
| Ataxia | 1 | 2023 | 305 | 0.180 |
Why?
|
| Germ Layers | 1 | 2021 | 71 | 0.180 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2021 | 152 | 0.180 |
Why?
|
| Brain Mapping | 5 | 2005 | 6568 | 0.180 |
Why?
|
| Osteoblasts | 2 | 1997 | 1142 | 0.180 |
Why?
|
| Cell Line | 15 | 2015 | 15620 | 0.180 |
Why?
|
| Cognition Disorders | 3 | 2012 | 3976 | 0.180 |
Why?
|
| Transfection | 10 | 2011 | 5781 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2021 | 4573 | 0.170 |
Why?
|
| Rare Diseases | 2 | 2024 | 619 | 0.170 |
Why?
|
| Fungal Proteins | 2 | 2002 | 911 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 235 | 0.170 |
Why?
|
| Cell Cycle | 4 | 2019 | 2934 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2018 | 1575 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 4013 | 0.170 |
Why?
|
| Hamartoma | 1 | 2022 | 235 | 0.170 |
Why?
|
| Oligosaccharides | 1 | 2022 | 405 | 0.170 |
Why?
|
| Neural Pathways | 3 | 2011 | 3040 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2006 | 2753 | 0.170 |
Why?
|
| Parvalbumins | 1 | 2021 | 260 | 0.170 |
Why?
|
| Corpus Striatum | 2 | 2004 | 1233 | 0.170 |
Why?
|
| Cell Size | 1 | 2001 | 624 | 0.160 |
Why?
|
| Adherens Junctions | 2 | 2011 | 89 | 0.160 |
Why?
|
| Alkaline Phosphatase | 7 | 2002 | 865 | 0.160 |
Why?
|
| Allelic Imbalance | 1 | 2019 | 77 | 0.160 |
Why?
|
| Mutagenesis | 2 | 2022 | 1234 | 0.160 |
Why?
|
| Haplotypes | 7 | 2014 | 2764 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 3 | 2020 | 1067 | 0.160 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 4 | 2005 | 330 | 0.160 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2008 | 2506 | 0.160 |
Why?
|
| Dyneins | 1 | 2019 | 124 | 0.160 |
Why?
|
| Gene Targeting | 3 | 2010 | 839 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2006 | 419 | 0.160 |
Why?
|
| Schizophrenia | 3 | 2024 | 6915 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 783 | 0.150 |
Why?
|
| Mammals | 2 | 2001 | 1131 | 0.150 |
Why?
|
| Cockayne Syndrome | 1 | 2017 | 20 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2018 | 2773 | 0.150 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2017 | 31 | 0.150 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 3758 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 315 | 0.150 |
Why?
|
| Amino Acid Sequence | 14 | 2019 | 13451 | 0.150 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 468 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2019 | 454 | 0.150 |
Why?
|
| Primates | 1 | 2020 | 523 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 895 | 0.150 |
Why?
|
| Olfactory Bulb | 1 | 1999 | 198 | 0.150 |
Why?
|
| Neurites | 1 | 1999 | 390 | 0.150 |
Why?
|
| Lysine | 1 | 2002 | 1001 | 0.150 |
Why?
|
| Neuromuscular Diseases | 2 | 2014 | 256 | 0.140 |
Why?
|
| Olivary Nucleus | 1 | 1998 | 128 | 0.140 |
Why?
|
| Karyotyping | 5 | 2010 | 1171 | 0.140 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 1430 | 0.140 |
Why?
|
| Genes, Immediate-Early | 1 | 1997 | 101 | 0.140 |
Why?
|
| Introns | 4 | 2016 | 978 | 0.140 |
Why?
|
| Language Development | 1 | 2018 | 181 | 0.140 |
Why?
|
| Cats | 4 | 2014 | 976 | 0.140 |
Why?
|
| Neurosurgery | 1 | 2023 | 670 | 0.140 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1697 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 5785 | 0.140 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2016 | 22 | 0.140 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 877 | 0.140 |
Why?
|
| Chromosome Disorders | 3 | 2022 | 499 | 0.140 |
Why?
|
| Sequence Alignment | 4 | 2015 | 2176 | 0.140 |
Why?
|
| Williams Syndrome | 2 | 2011 | 193 | 0.140 |
Why?
|
| Drosophila Proteins | 2 | 2023 | 1699 | 0.140 |
Why?
|
| Heterozygote | 5 | 2019 | 2798 | 0.140 |
Why?
|
| Turkey | 3 | 2013 | 249 | 0.140 |
Why?
|
| Sodium Channels | 1 | 2018 | 344 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2016 | 69 | 0.140 |
Why?
|
| Loss of Heterozygosity | 2 | 2017 | 659 | 0.130 |
Why?
|
| Genes, Lethal | 2 | 2012 | 225 | 0.130 |
Why?
|
| Pia Mater | 2 | 2008 | 87 | 0.130 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2014 | 458 | 0.130 |
Why?
|
| Genetic Loci | 2 | 2015 | 2618 | 0.130 |
Why?
|
| Corpus Callosum | 1 | 2001 | 749 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 2023 | 1688 | 0.130 |
Why?
|
| Middle Aged | 21 | 2024 | 220352 | 0.130 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2019 | 367 | 0.130 |
Why?
|
| Choroid Plexus | 1 | 2018 | 237 | 0.130 |
Why?
|
| Retina | 7 | 2000 | 2635 | 0.130 |
Why?
|
| Epigenomics | 1 | 2021 | 936 | 0.130 |
Why?
|
| Tretinoin | 2 | 2011 | 519 | 0.130 |
Why?
|
| Oncogenes | 1 | 2021 | 1220 | 0.130 |
Why?
|
| Epilepsies, Myoclonic | 1 | 1996 | 85 | 0.130 |
Why?
|
| Cysts | 1 | 2001 | 683 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 183 | 0.130 |
Why?
|
| Astrocytes | 1 | 2023 | 1338 | 0.120 |
Why?
|
| Rats, Long-Evans | 3 | 2002 | 378 | 0.120 |
Why?
|
| Cadherins | 3 | 2011 | 898 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 1846 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3663 | 0.120 |
Why?
|
| Pregnenediones | 1 | 1995 | 29 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 183 | 0.120 |
Why?
|
| Mice, Inbred C3H | 3 | 2007 | 915 | 0.120 |
Why?
|
| Muscular Diseases | 2 | 2011 | 551 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2015 | 1139 | 0.120 |
Why?
|
| Glycosylation | 6 | 2022 | 1096 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 1171 | 0.120 |
Why?
|
| Poly A | 1 | 2015 | 181 | 0.120 |
Why?
|
| Gene Library | 6 | 2001 | 1060 | 0.120 |
Why?
|
| Age Factors | 5 | 2021 | 18416 | 0.120 |
Why?
|
| Phosphoproteins | 3 | 2003 | 2440 | 0.120 |
Why?
|
| Basement Membrane | 2 | 2008 | 348 | 0.120 |
Why?
|
| Gestational Age | 6 | 2005 | 3565 | 0.120 |
Why?
|
| Apoptosis | 6 | 2022 | 9501 | 0.120 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 18137 | 0.120 |
Why?
|
| Saudi Arabia | 2 | 2005 | 209 | 0.120 |
Why?
|
| Tubulin | 4 | 2008 | 692 | 0.120 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 476 | 0.120 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2014 | 43 | 0.120 |
Why?
|
| Serum Response Element | 1 | 2013 | 7 | 0.110 |
Why?
|
| Phylogeny | 4 | 2023 | 2775 | 0.110 |
Why?
|
| Epilepsy, Complex Partial | 2 | 2004 | 56 | 0.110 |
Why?
|
| Genetic Testing | 7 | 2024 | 3531 | 0.110 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2007 | 167 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1959 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2015 | 1055 | 0.110 |
Why?
|
| Myocardium | 1 | 2006 | 4700 | 0.110 |
Why?
|
| Prednisolone | 1 | 1995 | 327 | 0.110 |
Why?
|
| Cell Shape | 1 | 2015 | 372 | 0.110 |
Why?
|
| Selection, Genetic | 2 | 2009 | 869 | 0.110 |
Why?
|
| Rhombencephalon | 1 | 2013 | 81 | 0.110 |
Why?
|
| Receptors, Cell Surface | 3 | 2017 | 2825 | 0.110 |
Why?
|
| Myopia | 2 | 2014 | 245 | 0.110 |
Why?
|
| Receptors, Notch | 2 | 2024 | 743 | 0.110 |
Why?
|
| Heart | 1 | 2006 | 4393 | 0.110 |
Why?
|
| Neural Crest | 2 | 2006 | 279 | 0.110 |
Why?
|
| Nerve Net | 3 | 2021 | 2261 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2005 | 315 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4264 | 0.110 |
Why?
|
| Genes, Dominant | 4 | 2006 | 863 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1652 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 3775 | 0.110 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2014 | 88 | 0.110 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 209 | 0.110 |
Why?
|
| Cell Fusion | 1 | 2013 | 293 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2017 | 704 | 0.110 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2013 | 63 | 0.110 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2013 | 72 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 3 | 1999 | 420 | 0.110 |
Why?
|
| Dihydropyridines | 1 | 2012 | 68 | 0.100 |
Why?
|
| Phospholipase C beta | 1 | 2012 | 49 | 0.100 |
Why?
|
| Electroencephalography | 6 | 2020 | 6189 | 0.100 |
Why?
|
| Muscle Hypotonia | 1 | 2014 | 160 | 0.100 |
Why?
|
| Lymphocytes | 3 | 2014 | 2611 | 0.100 |
Why?
|
| Fear | 2 | 2016 | 1462 | 0.100 |
Why?
|
| Fibroblasts | 4 | 2019 | 4090 | 0.100 |
Why?
|
| Genetic Vectors | 7 | 2002 | 3380 | 0.100 |
Why?
|
| Neostriatum | 2 | 2020 | 246 | 0.100 |
Why?
|
| Myoblasts | 1 | 2013 | 232 | 0.100 |
Why?
|
| Clathrin Heavy Chains | 1 | 2012 | 27 | 0.100 |
Why?
|
| Action Potentials | 1 | 2020 | 1816 | 0.100 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2015 | 122 | 0.100 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2012 | 24 | 0.100 |
Why?
|
| Computational Biology | 4 | 2021 | 3505 | 0.100 |
Why?
|
| Seizures, Febrile | 2 | 2012 | 108 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 1313 | 0.100 |
Why?
|
| Chondrocytes | 2 | 2007 | 791 | 0.100 |
Why?
|
| Open Reading Frames | 2 | 2021 | 814 | 0.100 |
Why?
|
| Genes, X-Linked | 2 | 2010 | 128 | 0.100 |
Why?
|
| Aged | 9 | 2024 | 169152 | 0.100 |
Why?
|
| Myxoma | 1 | 2012 | 114 | 0.100 |
Why?
|
| Translocation, Genetic | 4 | 2008 | 1388 | 0.100 |
Why?
|
| Blindness | 1 | 2015 | 582 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1617 | 0.100 |
Why?
|
| Memory | 2 | 2016 | 2179 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 381 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2009 | 373 | 0.100 |
Why?
|
| Septo-Optic Dysplasia | 1 | 2010 | 8 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2016 | 1152 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2005 | 4122 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 2192 | 0.090 |
Why?
|
| Crosses, Genetic | 2 | 2002 | 751 | 0.090 |
Why?
|
| Cell Count | 3 | 2002 | 1835 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 301 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1693 | 0.090 |
Why?
|
| Genetic Heterogeneity | 3 | 2011 | 724 | 0.090 |
Why?
|
| Cytoskeleton | 2 | 2014 | 1167 | 0.090 |
Why?
|
| Actinomycetales | 1 | 2010 | 31 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 12 | 2011 | 22023 | 0.090 |
Why?
|
| Fatal Outcome | 3 | 2006 | 1832 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 1997 | 1797 | 0.090 |
Why?
|
| Collagen Type IV | 1 | 2011 | 127 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2024 | 22053 | 0.090 |
Why?
|
| Conserved Sequence | 4 | 2008 | 1167 | 0.090 |
Why?
|
| Fingers | 1 | 2014 | 506 | 0.090 |
Why?
|
| Cyanobacteria | 1 | 2010 | 50 | 0.090 |
Why?
|
| Organ Specificity | 3 | 2021 | 1955 | 0.090 |
Why?
|
| Mitral Valve Prolapse | 1 | 2012 | 215 | 0.090 |
Why?
|
| Callithrix | 2 | 2020 | 93 | 0.090 |
Why?
|
| Thymidine | 3 | 1985 | 299 | 0.090 |
Why?
|
| Siblings | 3 | 2023 | 824 | 0.090 |
Why?
|
| CDC2 Protein Kinase | 1 | 2011 | 213 | 0.090 |
Why?
|
| Models, Genetic | 5 | 2009 | 3442 | 0.090 |
Why?
|
| HeLa Cells | 5 | 2019 | 3105 | 0.090 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2013 | 540 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2019 | 473 | 0.090 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 301 | 0.090 |
Why?
|
| Blotting, Southern | 2 | 2004 | 777 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 1737 | 0.090 |
Why?
|
| Software | 3 | 2020 | 4419 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2022 | 1889 | 0.090 |
Why?
|
| Alopecia | 2 | 2011 | 414 | 0.080 |
Why?
|
| Optic Chiasm | 2 | 1987 | 91 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 268 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2014 | 412 | 0.080 |
Why?
|
| Hypogonadism | 3 | 2011 | 801 | 0.080 |
Why?
|
| Age of Onset | 4 | 2021 | 3301 | 0.080 |
Why?
|
| Cobblestone Lissencephaly | 1 | 2008 | 2 | 0.080 |
Why?
|
| Protein Stability | 1 | 2011 | 566 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 503 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2007 | 2471 | 0.080 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 233 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4490 | 0.080 |
Why?
|
| Cloning, Molecular | 3 | 2006 | 4169 | 0.080 |
Why?
|
| Genes, Bacterial | 3 | 2010 | 1071 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2024 | 41335 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2012 | 459 | 0.080 |
Why?
|
| Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 2 | 2008 | 11 | 0.080 |
Why?
|
| Lamins | 1 | 2008 | 37 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 380 | 0.080 |
Why?
|
| Uniparental Disomy | 1 | 2008 | 45 | 0.080 |
Why?
|
| Dendritic Spines | 1 | 2010 | 243 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2101 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2008 | 377 | 0.080 |
Why?
|
| Middle East | 1 | 2008 | 230 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2003 | 1991 | 0.070 |
Why?
|
| Sequence Analysis | 1 | 2008 | 240 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 719 | 0.070 |
Why?
|
| Polymorphism, Genetic | 4 | 2008 | 4291 | 0.070 |
Why?
|
| Enterobactin | 1 | 2007 | 12 | 0.070 |
Why?
|
| Fetal Death | 3 | 2002 | 434 | 0.070 |
Why?
|
| Catechols | 1 | 2007 | 62 | 0.070 |
Why?
|
| beta Catenin | 2 | 2003 | 1043 | 0.070 |
Why?
|
| Massachusetts | 1 | 2020 | 8803 | 0.070 |
Why?
|
| Yersinia pestis | 1 | 2007 | 33 | 0.070 |
Why?
|
| Neurosurgical Procedures | 3 | 2023 | 2056 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2012 | 2913 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2007 | 42 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 58995 | 0.070 |
Why?
|
| Gorilla gorilla | 2 | 2023 | 29 | 0.070 |
Why?
|
| Head | 1 | 2013 | 922 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 133 | 0.070 |
Why?
|
| Gene Duplication | 2 | 2011 | 313 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2014 | 1612 | 0.070 |
Why?
|
| Eye | 1 | 2011 | 710 | 0.070 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2009 | 306 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2002 | 1529 | 0.070 |
Why?
|
| Genetic Markers | 3 | 2010 | 2608 | 0.070 |
Why?
|
| Computer Simulation | 4 | 2017 | 6218 | 0.070 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2006 | 14 | 0.070 |
Why?
|
| Chick Embryo | 2 | 2007 | 981 | 0.070 |
Why?
|
| Psychomotor Disorders | 1 | 2007 | 149 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2023 | 80372 | 0.070 |
Why?
|
| Dentate Gyrus | 1 | 2007 | 163 | 0.070 |
Why?
|
| Aborted Fetus | 1 | 2006 | 11 | 0.070 |
Why?
|
| Cytogenetics | 1 | 2007 | 198 | 0.070 |
Why?
|
| Transport Vesicles | 1 | 2007 | 81 | 0.070 |
Why?
|
| Chromosome Inversion | 1 | 2007 | 120 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1120 | 0.070 |
Why?
|
| Macaca mulatta | 3 | 2023 | 2316 | 0.070 |
Why?
|
| Microscopy, Electron | 4 | 2019 | 2558 | 0.070 |
Why?
|
| Protein Binding | 4 | 2022 | 9335 | 0.070 |
Why?
|
| Thalamus | 2 | 2011 | 1041 | 0.070 |
Why?
|
| Oxazoles | 1 | 2007 | 199 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2014 | 1516 | 0.070 |
Why?
|
| Gene Silencing | 3 | 2014 | 1513 | 0.070 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2005 | 23 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10551 | 0.060 |
Why?
|
| Tissue Survival | 1 | 2006 | 119 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1705 | 0.060 |
Why?
|
| Catalysis | 1 | 2007 | 775 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2006 | 3735 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2859 | 0.060 |
Why?
|
| Drosophila | 3 | 2023 | 1492 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2852 | 0.060 |
Why?
|
| Echocardiography | 1 | 2018 | 4981 | 0.060 |
Why?
|
| Germ Cells | 2 | 2021 | 635 | 0.060 |
Why?
|
| Intelligence | 2 | 2013 | 921 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1995 | 1796 | 0.060 |
Why?
|
| Morphogenesis | 3 | 2001 | 740 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 1262 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 3276 | 0.060 |
Why?
|
| T-Box Domain Proteins | 2 | 2010 | 468 | 0.060 |
Why?
|
| Parathyroid Hormone-Related Protein | 2 | 1997 | 327 | 0.060 |
Why?
|
| Teratogens | 1 | 2005 | 117 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2002 | 814 | 0.060 |
Why?
|
| Pakistan | 2 | 2003 | 304 | 0.060 |
Why?
|
| Paresis | 1 | 2006 | 177 | 0.060 |
Why?
|
| Cerebellar Ataxia | 1 | 2006 | 149 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6238 | 0.060 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2004 | 37 | 0.060 |
Why?
|
| Electroporation | 1 | 2006 | 255 | 0.060 |
Why?
|
| Histological Techniques | 1 | 1984 | 194 | 0.060 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2004 | 16 | 0.060 |
Why?
|
| Urogenital Abnormalities | 1 | 2007 | 256 | 0.060 |
Why?
|
| beta-Galactosidase | 5 | 2011 | 575 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2003 | 1802 | 0.060 |
Why?
|
| Reading | 1 | 2007 | 529 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2007 | 1085 | 0.060 |
Why?
|
| Gene Order | 1 | 2004 | 169 | 0.060 |
Why?
|
| Autoradiography | 1 | 1984 | 730 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 7021 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2012 | 1486 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 622 | 0.060 |
Why?
|
| Yemen | 1 | 2003 | 9 | 0.060 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 340 | 0.060 |
Why?
|
| Phenols | 1 | 2007 | 514 | 0.050 |
Why?
|
| Homeostasis | 1 | 2014 | 3306 | 0.050 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 11071 | 0.050 |
Why?
|
| Prion Diseases | 1 | 2024 | 98 | 0.050 |
Why?
|
| RNA Interference | 2 | 2010 | 2846 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2004 | 186 | 0.050 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2003 | 168 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2005 | 534 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2006 | 459 | 0.050 |
Why?
|
| Fetal Viability | 1 | 2002 | 23 | 0.050 |
Why?
|
| France | 1 | 2004 | 511 | 0.050 |
Why?
|
| Receptors, Cytoadhesin | 1 | 2002 | 8 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 74359 | 0.050 |
Why?
|
| Blotting, Northern | 3 | 2005 | 1543 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20080 | 0.050 |
Why?
|
| Health Surveys | 1 | 2012 | 4063 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 611 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2004 | 226 | 0.050 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 2002 | 113 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2011 | 1792 | 0.050 |
Why?
|
| DNA Probes | 2 | 2003 | 551 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2007 | 521 | 0.050 |
Why?
|
| Dogs | 1 | 2007 | 3841 | 0.050 |
Why?
|
| Retinal Ganglion Cells | 2 | 1985 | 806 | 0.050 |
Why?
|
| Bone and Bones | 2 | 2016 | 2560 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2006 | 296 | 0.050 |
Why?
|
| Adipokines | 1 | 2024 | 311 | 0.050 |
Why?
|
| Multigene Family | 1 | 2005 | 1077 | 0.050 |
Why?
|
| Atrophy | 2 | 2023 | 1627 | 0.050 |
Why?
|
| Membrane Glycoproteins | 3 | 2012 | 3707 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2007 | 651 | 0.050 |
Why?
|
| Mutagens | 1 | 2022 | 178 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 952 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2004 | 441 | 0.050 |
Why?
|
| Ocular Motility Disorders | 1 | 2003 | 143 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 351 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2003 | 385 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 2255 | 0.050 |
Why?
|
| Microinjections | 1 | 2002 | 321 | 0.050 |
Why?
|
| Antibody Diversity | 1 | 2021 | 72 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2001 | 161 | 0.050 |
Why?
|
| Lateral Ventricles | 1 | 2002 | 146 | 0.050 |
Why?
|
| Hypothalamus | 2 | 2022 | 998 | 0.050 |
Why?
|
| Vibrio cholerae | 1 | 2007 | 793 | 0.050 |
Why?
|
| Dimerization | 1 | 2002 | 891 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2001 | 99 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 3800 | 0.050 |
Why?
|
| Anticonvulsants | 2 | 2004 | 1879 | 0.050 |
Why?
|
| Cell Death | 1 | 2006 | 1672 | 0.050 |
Why?
|
| Abortion, Spontaneous | 1 | 2006 | 530 | 0.050 |
Why?
|
| Binding Sites | 3 | 2024 | 6048 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3527 | 0.050 |
Why?
|
| Neurofibromatosis 1 | 1 | 2006 | 560 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1121 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3790 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1612 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2004 | 580 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2021 | 211 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2007 | 1066 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2007 | 1091 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2002 | 631 | 0.040 |
Why?
|
| Genome | 1 | 2008 | 1739 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2021 | 184 | 0.040 |
Why?
|
| Cell Survival | 1 | 2010 | 5797 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2002 | 568 | 0.040 |
Why?
|
| CpG Islands | 1 | 2024 | 1221 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2011 | 8313 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 728 | 0.040 |
Why?
|
| Japan | 1 | 2004 | 1369 | 0.040 |
Why?
|
| Thiazoles | 1 | 2007 | 1511 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2001 | 342 | 0.040 |
Why?
|
| Reaction Time | 2 | 2005 | 2075 | 0.040 |
Why?
|
| Basal Ganglia Diseases | 2 | 2011 | 144 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 2000 | 151 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 2864 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2001 | 2629 | 0.040 |
Why?
|
| Growth Substances | 1 | 2001 | 768 | 0.040 |
Why?
|
| Receptor, Notch2 | 1 | 1999 | 87 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 2 | 2011 | 169 | 0.040 |
Why?
|
| Nuclear Family | 1 | 2000 | 313 | 0.040 |
Why?
|
| Chromosome Walking | 1 | 1998 | 25 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 195 | 0.040 |
Why?
|
| Cytokinesis | 1 | 2020 | 172 | 0.040 |
Why?
|
| Recombinant Proteins | 4 | 1998 | 6538 | 0.040 |
Why?
|
| Facies | 1 | 2019 | 223 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2007 | 1726 | 0.040 |
Why?
|
| Sequence Tagged Sites | 1 | 1998 | 94 | 0.040 |
Why?
|
| Bromodeoxyuridine | 2 | 2010 | 311 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 1067 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 3442 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 562 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2000 | 1060 | 0.040 |
Why?
|
| Tongue | 1 | 2022 | 404 | 0.040 |
Why?
|
| Xenopus | 1 | 2000 | 717 | 0.040 |
Why?
|
| Chromosome Fragility | 1 | 1998 | 16 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2005 | 1866 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 1246 | 0.040 |
Why?
|
| Face | 1 | 2004 | 1017 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2014 | 2907 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2020 | 1553 | 0.040 |
Why?
|
| Logistic Models | 1 | 2012 | 13314 | 0.040 |
Why?
|
| Cues | 1 | 2003 | 867 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 426 | 0.040 |
Why?
|
| Colchicine | 1 | 1999 | 261 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2007 | 3682 | 0.040 |
Why?
|
| Epithelium | 1 | 2002 | 1605 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 829 | 0.040 |
Why?
|
| Dwarfism | 1 | 2018 | 137 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 1999 | 226 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 2 | 2008 | 182 | 0.040 |
Why?
|
| Heart Defects, Congenital | 2 | 2012 | 4673 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 900 | 0.040 |
Why?
|
| Collagen | 1 | 2005 | 2636 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2003 | 595 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 3826 | 0.040 |
Why?
|
| DNA, Viral | 2 | 1995 | 2194 | 0.040 |
Why?
|
| Hybrid Cells | 1 | 1997 | 422 | 0.040 |
Why?
|
| Motor Activity | 2 | 2008 | 2687 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6853 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1007 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2000 | 780 | 0.040 |
Why?
|
| Paired Box Transcription Factors | 2 | 2010 | 207 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2018 | 329 | 0.030 |
Why?
|
| Cystatin B | 1 | 1996 | 12 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 1999 | 495 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1997 | 852 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2001 | 841 | 0.030 |
Why?
|
| Cystatins | 1 | 1996 | 55 | 0.030 |
Why?
|
| Recombination, Genetic | 3 | 2007 | 1526 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2000 | 511 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 2016 | 229 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1997 | 207 | 0.030 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1996 | 189 | 0.030 |
Why?
|
| Integrins | 1 | 2000 | 839 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2011 | 3484 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2003 | 1266 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 8158 | 0.030 |
Why?
|
| Diabetes Mellitus | 2 | 2011 | 5889 | 0.030 |
Why?
|
| Staining and Labeling | 2 | 1997 | 1089 | 0.030 |
Why?
|
| Abortion, Habitual | 1 | 1996 | 61 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2019 | 3969 | 0.030 |
Why?
|
| Quality Control | 1 | 2018 | 828 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1997 | 491 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2002 | 2698 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 802 | 0.030 |
Why?
|
| Observer Variation | 1 | 2021 | 2601 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10827 | 0.030 |
Why?
|
| Aminoacylation | 1 | 2014 | 9 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2013 | 1132 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6965 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1997 | 1649 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5870 | 0.030 |
Why?
|
| Myogenin | 1 | 2013 | 55 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 53 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3539 | 0.030 |
Why?
|
| Eye Proteins | 2 | 2010 | 633 | 0.030 |
Why?
|
| Proteomics | 1 | 2007 | 3817 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2026 | 0.030 |
Why?
|
| Cephalometry | 1 | 2015 | 382 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 16939 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2008 | 9287 | 0.030 |
Why?
|
| Epilepsy, Generalized | 1 | 1996 | 178 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 1755 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 522 | 0.030 |
Why?
|
| Risk | 1 | 2005 | 9631 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2013 | 48 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 4048 | 0.030 |
Why?
|
| MyoD Protein | 1 | 2013 | 142 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2022 | 1710 | 0.030 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2013 | 135 | 0.030 |
Why?
|
| Cerebellar Diseases | 1 | 2015 | 219 | 0.030 |
Why?
|
| Arabs | 2 | 2006 | 187 | 0.030 |
Why?
|
| Learning | 1 | 2002 | 1739 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 208 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 663 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3113 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2012 | 94 | 0.030 |
Why?
|
| Qatar | 1 | 2011 | 40 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2012 | 220 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 716 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2014 | 226 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 475 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 1992 | 81 | 0.020 |
Why?
|
| Muscles | 1 | 2016 | 1581 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 1997 | 897 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 2698 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 1993 | 284 | 0.020 |
Why?
|
| Spain | 1 | 2013 | 488 | 0.020 |
Why?
|
| Cells | 1 | 1993 | 164 | 0.020 |
Why?
|
| Vertebrates | 1 | 1993 | 228 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2008 | 781 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2006 | 2262 | 0.020 |
Why?
|
| Holoenzymes | 1 | 2011 | 40 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2002 | 2093 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 12922 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2009 | 3615 | 0.020 |
Why?
|
| Dissection | 1 | 2013 | 298 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2011 | 51 | 0.020 |
Why?
|
| Proviruses | 1 | 1993 | 313 | 0.020 |
Why?
|
| Transglutaminases | 1 | 2012 | 197 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2011 | 122 | 0.020 |
Why?
|
| Lac Operon | 1 | 2011 | 237 | 0.020 |
Why?
|
| Aging, Premature | 1 | 2011 | 44 | 0.020 |
Why?
|
| Necrosis | 2 | 2006 | 1612 | 0.020 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2011 | 112 | 0.020 |
Why?
|
| Protein Transport | 2 | 2007 | 1964 | 0.020 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 324 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2011 | 133 | 0.020 |
Why?
|
| RNA | 1 | 2020 | 2722 | 0.020 |
Why?
|
| Proteome | 2 | 2013 | 1855 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2015 | 983 | 0.020 |
Why?
|
| Microcirculation | 2 | 2007 | 1278 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 633 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 2186 | 0.020 |
Why?
|
| Lamin Type A | 1 | 2011 | 187 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2011 | 163 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1995 | 1257 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 1993 | 897 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 8950 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 6131 | 0.020 |
Why?
|
| Kinetics | 1 | 1997 | 6377 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 695 | 0.020 |
Why?
|
| Australia | 1 | 2013 | 1289 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 613 | 0.020 |
Why?
|
| Progeria | 1 | 2011 | 188 | 0.020 |
Why?
|
| Hypertelorism | 1 | 2008 | 29 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2010 | 192 | 0.020 |
Why?
|
| ran GTP-Binding Protein | 1 | 2008 | 51 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1992 | 588 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15289 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2022 | 4373 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 144 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 9185 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2008 | 159 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2008 | 228 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2012 | 951 | 0.020 |
Why?
|
| United States | 1 | 2016 | 72461 | 0.020 |
Why?
|
| Serotonin | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2105 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2000 | 2496 | 0.020 |
Why?
|
| Encephalocele | 1 | 2008 | 135 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 1995 | 2414 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1995 | 1758 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 747 | 0.020 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1987 | 139 | 0.020 |
Why?
|
| Sensation | 1 | 2008 | 331 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1972 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2006 | 44 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 3084 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2011 | 1134 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 2007 | 147 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2007 | 246 | 0.020 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2007 | 118 | 0.020 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1985 | 47 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 833 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2008 | 5434 | 0.020 |
Why?
|
| Silver Staining | 1 | 2005 | 63 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1985 | 166 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2007 | 404 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2006 | 236 | 0.020 |
Why?
|
| Nocodazole | 1 | 2005 | 95 | 0.020 |
Why?
|
| Hernia, Inguinal | 1 | 2008 | 220 | 0.020 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2006 | 158 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2006 | 384 | 0.020 |
Why?
|
| Proteinuria | 1 | 2008 | 594 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15687 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2008 | 407 | 0.020 |
Why?
|
| Time | 1 | 2007 | 545 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 1 | 2006 | 136 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 15840 | 0.020 |
Why?
|
| Microtomy | 1 | 1984 | 44 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 1744 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 563 | 0.020 |
Why?
|
| Elastin | 1 | 2006 | 301 | 0.010 |
Why?
|
| Pongo pygmaeus | 1 | 2004 | 3 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2008 | 551 | 0.010 |
Why?
|
| Tritium | 1 | 1985 | 707 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 1485 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 2057 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 375 | 0.010 |
Why?
|
| Helper Viruses | 2 | 1995 | 40 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2006 | 337 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 755 | 0.010 |
Why?
|
| Lectins | 1 | 1985 | 484 | 0.010 |
Why?
|
| Maze Learning | 1 | 2005 | 477 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3765 | 0.010 |
Why?
|
| Indicators and Reagents | 2 | 1995 | 461 | 0.010 |
Why?
|
| Putamen | 1 | 2004 | 291 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 2004 | 249 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 590 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 401 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 459 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 623 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 11847 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9716 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2007 | 20509 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2007 | 1122 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2008 | 3094 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6216 | 0.010 |
Why?
|
| Cattle | 1 | 2007 | 3847 | 0.010 |
Why?
|
| Kidney | 2 | 2007 | 7064 | 0.010 |
Why?
|
| Israel | 1 | 2004 | 722 | 0.010 |
Why?
|
| Rabbits | 1 | 2007 | 4773 | 0.010 |
Why?
|
| Shock, Septic | 1 | 2007 | 761 | 0.010 |
Why?
|
| Integrin alpha3beta1 | 1 | 2000 | 53 | 0.010 |
Why?
|
| Ephrin-A5 | 1 | 2000 | 17 | 0.010 |
Why?
|
| Anemia | 1 | 2010 | 1511 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3610 | 0.010 |
Why?
|
| Biopolymers | 1 | 2000 | 184 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2000 | 180 | 0.010 |
Why?
|
| Myelin Proteolipid Protein | 1 | 1999 | 107 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 854 | 0.010 |
Why?
|
| Mice, Inbred Strains | 2 | 1993 | 1763 | 0.010 |
Why?
|
| Amino Acids | 1 | 1985 | 1714 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24123 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2006 | 1264 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2007 | 1817 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 929 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4925 | 0.010 |
Why?
|
| Anthropometry | 1 | 2002 | 1348 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2651 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2008 | 1634 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2007 | 1870 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 13981 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 867 | 0.010 |
Why?
|
| Microscopy | 1 | 2001 | 885 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 1599 | 0.010 |
Why?
|
| Ischemia | 1 | 2004 | 1893 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2006 | 1915 | 0.010 |
Why?
|
| Pneumonia | 1 | 2007 | 2131 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 2985 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29658 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 2802 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 783 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10547 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1995 | 4219 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1992 | 530 | 0.010 |
Why?
|
| Genes, myc | 1 | 1992 | 395 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 5075 | 0.010 |
Why?
|
| Sleep | 1 | 2005 | 4751 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13502 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 4878 | 0.000 |
Why?
|
| Ultrasonography | 1 | 2001 | 5961 | 0.000 |
Why?
|
| Virus Replication | 1 | 1995 | 2432 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1995 | 2838 | 0.000 |
Why?
|
| Inflammation | 1 | 2004 | 10756 | 0.000 |
Why?
|